Timothy L. Main's most recent trade in Quest Diagnostics, Inc. was a trade of 1,203 Common Stock done . Disclosure was reported to the exchange on May 15, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Quest Diagnostics, Inc. | Timothy L. Main | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 1,203 | 26,297 (0%) | 0% | 0 | Common Stock | |
Quest Diagnostics, Inc. | Timothy L. Main | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 1,482 | 25,094 (0%) | 0% | 0 | Common Stock | |
Quest Diagnostics, Inc. | Timothy L. Main | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 1,369 | 23,612 (0%) | 0% | 0 | Common Stock | |
Quest Diagnostics, Inc. | Timothy L. Main | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 1,292 | 22,243 (0%) | 0% | 0 | Common Stock | |
Quest Diagnostics, Inc. | Timothy L. Main | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 1,363 | 20,951 (0%) | 0% | 0 | Common Stock | |
Jabil Inc | Timothy L. Main | Director | Sale of securities on an exchange or to another person at price $ 44.48 per share. | 17 Dec 2020 | 35,000 | 263,383 (0%) | 0% | 44.5 | 1,556,800 | Common Stock |
Jabil Inc | Timothy L. Main | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2020 | 5,800 | 298,383 (0%) | 0% | 0 | Common Stock | |
Jabil Inc | Timothy L. Main | Director | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 03 Aug 2020 | 15,000 | 292,583 (0%) | 0% | 35 | 525,000 | Common Stock |